Regeneron Pharmaceuticals, Inc.
ANTI-FGFR2 ANTIBODIES AND METHODS OF USE THEREOF
Last updated:
Abstract:
Provided herein are monoclonal antibodies, and antigen-binding fragments thereof, that bind fibroblast growth factor receptor 2 (FGFR2), and methods of use thereof and methods of use thereof. Also included are antibody-drug conjugates (ADCs) comprising the anti-FGFR2 antibodies or antigen-binding fragments thereof linked to a cytotoxic agent, radionuclide, or other moiety, as well as methods of treatment using the same.
Status:
Application
Type:
Utility
Filling date:
21 Oct 2021
Issue date:
26 May 2022